Revance Therapeutics, Inc. (NASDAQ:RVNC) Receives Consensus Recommendation of “Hold” from Brokerages
Revance Therapeutics, Inc. (NASDAQ:RVNC – Get Free Report) has received an average recommendation of “Hold” from the nine analysts that are presently covering the firm, MarketBeat.com reports. Eight equities research analysts have rated the stock with a hold recommendation and one has given a buy recommendation to the company. The average 1-year price objective among […]
Revance Therapeutics, Inc. (NASDAQ:RVNC – Get Free Report) has received an average recommendation of “Hold” from the nine analysts that are presently covering the firm, MarketBeat.com reports. Eight equities research analysts have rated the stock with a hold recommendation and one has given a buy recommendation to the company. The average 1-year price objective among […]
